Table 2.
Antibiotics prescribed, indication for treatment mentioned in notes and compliance rates with local antibiotic policy for patients who received antibiotic treatment during the point prevalence surveys May 2008 and May 2009 (Antrim Area Hospital compared with all European hospitals)
| Characteristics | Point prevalence survey-May 2008 Antrim Area Hospital Number of patients (%)* | All hospitals (n= 50) (%) of patients† | Point prevalence survey-May 2009 Antrim Area Hospital Number of patients (%)* | All hospitals (n= 172) (%) of patients† |
|---|---|---|---|---|
| Antibiotic prescriptions | ||||
| Tetracyclines (J01AA) | 1 (1) | 1 (0–1) | 0 (0) | 1 (0–3) |
| Penicillins with extended spectrum (J01CA) | 3 (2) | 4 (1–6) | 5 (4) | 5 (3–10) |
| Beta-lactamase sensitive penicillins (J01CE) | 5 (3) | 4 (1–7) | 6 (5) | 3 (1–8) |
| Beta-lactamase resistant penicillins (J01CF) | 10 (7) | 3 (1–8) | 7 (5) | 8 (3–12) |
| Combinations of penicillins including beta-lactamase inhibitors (J01CR) | 75 (52) | 21 (9–30) | 56 (43) | 34 (21–42) |
| First generation cephalosporins (J01DB) | 2 (1) | 3 (1–11) | 0 (0) | 1 (0–6) |
| Second generation cephalosporins (J01DC) | 0 (0) | 6 (2–12) | 0 (0) | 3 (0–10) |
| Third generation cephalosporins (J01DD) | 3 (2) | 7 (3–13) | 4 (3) | 3 (2–9) |
| Monobactams (J01DF) | 4 (3) | 1 (0–2) | 6 (5) | 0 |
| Carbapenems (J01DH) | 5 (3) | 4 (1–7) | 4 (3) | 4 (1–7) |
| Trimethoprim and derivatives (J01EA) | 3 (2) | 4 (1–5) | 5 (4) | 1 (0–7) |
| Macrolides (J01FA) | 21 (15) | 3 (1–5) | 15 (12) | 6 (3–12) |
| Other aminoglycosides (J01GB) | 1 (1) | 6 (3–7) | 4 (3) | 5 (2–9) |
| Fluoroquinolones (J01MA) | 1 (1) | 13 (7–17) | 2 (2) | 12 (6–20) |
| Glycopeptide antibacterials (J01XA) | 3 (2) | 5 (1–6) | 10 (8) | 5 (1–9) |
| Imidazole derivatives (J01XD) | 3 (2) | 5 (3–7) | 5 (4) | 6 (3–11) |
| Other antibacterials (J01XX) | 2 (1) | 1 (0–1) | 0 (0) | 0 (0–1) |
| Indication for treatment mentioned in notes | 136 (90) | 80 (55–90) | 110 (81) | 80 (70–88) |
| Compliance with the hospital antibiotic policy | NA‡ | NA‡ | 54 (70) | 75 (55–84) |
*
Data are expressed as number of patients and percentages.
†
Data are expressed as median of hospitals' percentages and interquartiles.
‡
NA, data not available; measuring compliance with hospital antibiotic policies was considered only in the second point prevalence survey.